Samuel Ponce‐de‐León

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico”.

Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico

npj Vaccines(2023)10.1038/s41541-023-00662-6

N/A

1.1DataRank · unranked

47 citations

Martha Torres, Luis Enrique Soto-Ramírez, Juan J. Calva, Patricio Santillán‐Doherty, Dora Eugenia Carranza-Salazar +28 more

Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico

medRxiv(2022)10.1101/2022.02.08.22270676

N/A

1.1DataRank · unranked

26 citations

Martha Torres, Luis Enrique Soto-Ramírez, Juan J. Calva, Patricio Santillán‐Doherty, Dora Eugenia Carranza-Salazar +28 more